Skip to main content

Beyond Meat, DraftKings, Overstock: 5 Top Stock Gainers for Tuesday

Beyond Meat, DraftKings,, Lordstown Motors and Tilray are five top stock gainers for Tuesday.
  • Author:
  • Publish date:

Stocks finished down Tuesday as Wall Street digested solid corporate earnings reports and concern that a coronavirus relief package could be delayed.

Here are some of the top gainers for Tuesday:

1. Beyond Meat | Percentage Increase 18%

Beyond Meat  (BYND) - Get Beyond Meat, Inc. Report surged to a six-month high Tuesday after the plant-based-food company reached a partnership deal with PepsiCo  (PEP) - Get PepsiCo, Inc. Report to produce and market a new line of snacks. 

2. DraftKings | Percentage Increase 5.4%

DraftKings  (DKNG) - Get DraftKings Inc Class A Report was climbing after Goldman Sachs analyst Stephen Grambling upgraded shares of the digital gambling company to buy from neutral with a price target of $65, up from $45. 

Grambling recommended buying the market leaders in the "still-emerging" online sports betting industry.

Scroll to Continue

TheStreet Recommends

3. | Percentage Increase 28%  (OSTK) - Get, Inc. Report jumped after the online retailer said that it would convert its blockchain-focused subsidiary, Medici Ventures, to a limited partnership and Pelion Venture Partners will act as a general partner of the fund.

4. Lordstown Motors | Percentage Increase 14%

Shares of Lordstown Motors  (RIDE) - Get Lordstown Motors Corp. Class A Report and other electric vehicle makers were surging after President Joe Biden said he planned to replace the "enormous" fleet of government vehicles with electric models assembled in the U.S. 

As of 2019, nearly 650,000 vehicles were in the federal government’s fleet.

5. Tilray | Percentage Increase 11%

Tilray  (TLRY) - Get Tilray Brands, Inc. Report was rising after saying that the French government tapped it to provide cannabis for medical experiments. 

Tilray said its products will be administered to qualifying patients for whom existing treatments do not provide sufficient relief from their symptoms.